Treatment With Pyrotinib-Based Therapy in Lapatinib Resistant HER2-Positive Metastatic Breast Cancer
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pyrotinib
Sponsor: The First Affiliated Hospital with Nanjing Medical University